Youth leadership matters.
CLICK HERE to read the joint guidance notice from the WFH, the EAHAD, the EHC, and U.S. National Hemophilia Foundation with regards to the COVID-19 vaccine.
The Association of Hemophilia Clinic Directors of Canada (AHCDC) has issued a message to address the most frequent questions asked with regards to the COVID-19 vaccine and bleeding disorders: CLICK HERE.
Special Additional Call for Applications - CHS Research programs
The Canadian Hemophilia Society (CHS) is pleased to put out a special call for applications for two of its research programs for the 2021-2022 grant period: the CHS/Novo Nordisk Psychosocial Research Program and the CHS – Bayer – ADVANCE Canada Research Program.
Deadline: 5:00 PM January 18, 2021 (Grant period of April 2021 to March 2022)